Procter & Gamble’s fiscal first-quarter 2027 earnings release on October 22 anchors trader focus, with Wall Street consensus pointing to roughly 2% organic sales growth amid stabilizing U.S. consumption trends and mixed international results. The company’s full-year 1-3% guidance incorporates a 30-50 basis point headwind from product discontinuations plus roughly $1 billion in after-tax commodity, energy, and transportation cost pressures tied to geopolitical factors. Recent channel data show U.S. shopper purchases accelerating to 4.4% in the latest tracked period, supporting volume recovery, while pricing and mix contributions remain modest. The tightly bunched Polymarket probabilities—led by the 2.5-3.5% outcome at 27.5%—reflect uncertainty over whether Q1 volumes and category share gains can offset ongoing margin compression and deliver toward the upper end of the annual range.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено1H6H1D7D30DALL
View resolved

Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы